BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//OncoPlanning//Event//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:b41b2665-b73a-4fa8-8ced-750523d7d154@oncoplanning
DTSTAMP:20261121T124936Z
DTSTART;VALUE=DATE:20261124
DTEND;VALUE=DATE:20261124
SUMMARY:GOC-ESGO 2nd Joint Webinar: Mirvetuximab Soravtansine (MIRV) and the Growing Real-World Evidence Emerging from European Practice
DESCRIPTION:Joint ESGO–GOC webinar on mirvetuximab soravtansine in ovarian cancer and emerging real-world evidence from European practice.
LOCATION:Online
URL:https://eacademy.esgo.org/esgo/2026/2026-webinars/4237258
END:VEVENT
END:VCALENDAR